Danske Bank’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09K Hold
600
﹤0.01% 923
2026
Q1
$3.27K Sell
600
-800
-57% -$4.49K ﹤0.01% 954
2025
Q4
$9.8K Hold
1,400
﹤0.01% 1318
2025
Q3
$10.8K Hold
1,400
﹤0.01% 1259
2025
Q2
$12.2K Hold
1,400
﹤0.01% 1266
2025
Q1
$11.1K Hold
1,400
﹤0.01% 1064
2024
Q4
$12.7K Sell
1,400
-16,900
-92% -$163K ﹤0.01% 1073
2024
Q3
$168K Buy
18,300
+12,200
+200% +$101K ﹤0.01% 952
2024
Q2
$59.7K Buy
6,100
+4,200
+221% +$51.2K ﹤0.01% 969
2024
Q1
$28.7K Buy
+1,900
New +$34.5K ﹤0.01% 1011

Other funds holding TDOC

Danske Bank's TDOC Position: Q2 2026 in Review

Danske Bank held its Teladoc Health (TDOC) position steady in Q2 2026 at 600 shares worth $5.09K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Danske Bank first reported a position in TDOC in Q1 2024 and has held it in 10 quarters since. The position peaked at $168K in Q3 2024. 257 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Danske Bank held 600 shares of Teladoc Health worth $5.09K as of Q2 2026.
  • Danske Bank left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #923 holding.
  • Danske Bank first reported a position in Teladoc Health in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Teladoc Health position peaked at $168K in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.